+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metabolomics Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446106
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • AB Sciex
  • Biocrates Life Sciences
  • Bruker
  • Danaher Corporation
  • Kore Technologies Ltd.
  • Metabolon
Metabolomics Global Market Report 2021: COVID-19 Growth and Change to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global metabolomics market.







The report focuses on the metabolomics market which is experiencing strong growth. The report gives a guide to the metabolomics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for metabolomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Metabolomics Market Global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope


Markets Covered:


  • By Product & Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools & Services
  • By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomics; Personalized Medicine; Others
  • By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors of Metabolism; Others
  • By Metabolomics Instruments: Separation Techniques; Detection Techniques
  • By Metabolomics Bioinformatics Tools & Services: Bioinformatics Tools and Database; Bioinformatics Services

Companies Mentioned:


Human Metabolome Technologies; Metabolon; Bio-Rad Laboratories; Bruker; Agilent Technologies

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data Segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Metabolomics Market

What is the estimated value of the Global Metabolomics Market?

The Global Metabolomics Market was estimated to be valued at $2.3 billion in 2021.

What is the growth rate of the Global Metabolomics Market?

The growth rate of the Global Metabolomics Market is 12.3%, with an estimated value of $3.6 billion by 2025.

What is the forecasted size of the Global Metabolomics Market?

The Global Metabolomics Market is estimated to be worth $3.6 billion by 2025.

Who are the key companies in the Global Metabolomics Market?

Key companies in the Global Metabolomics Market include Human Metabolome Technologies, Metabolon, Bio, Rad Laboratories, Bruker, Agilent Technologies, Thermo Fisher, Waters and Shimadzu.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Sciex
  • Biocrates Life Sciences
  • Bruker
  • Danaher Corporation
  • Kore Technologies Ltd.
  • Metabolon

1. Executive Summary2. Metabolomics Market Characteristics3. Metabolomics Market Trends and Strategies4. Impact Of COVID-19 On Metabolomics
5. Metabolomics Market Size and Growth
5.1. Global Metabolomics Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Metabolomics Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Metabolomics Market Segmentation
6.1. Global Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools & Services
6.2. Global Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Others
6.3. Global Metabolomics Market, Segmentation by Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others
6.4. Global Metabolomics Market, Segmentation by Metabolomics Instruments, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Separation Techniques
  • Detection Techniques
6.5. Global Metabolomics Market, Segmentation by Metabolomics Bioinformatics Tools & Services, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Bioinformatics Tools and Database
  • Bioinformatics Services

7. Metabolomics Market Regional and Country Analysis
7.1. Global Metabolomics Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Metabolomics Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Metabolomics Market
8.1. Asia-Pacific Metabolomics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Metabolomics Market
9.1. China Metabolomics Market Overview
9.2. China Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Metabolomics Market
10.1. India Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Metabolomics Market
11.1. Japan Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Metabolomics Market
12.1. Australia Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Metabolomics Market
13.1. Indonesia Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Metabolomics Market
14.1. South Korea Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Metabolomics Market
15.1. Western Europe Metabolomics Market Overview
15.2. Western Europe Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Metabolomics Market
16.1. UK Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Metabolomics Market
17.1. Germany Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Metabolomics Market
18.4. France Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Metabolomics Market
19.1. Eastern Europe Metabolomics Market Overview
19.2. Eastern Europe Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Metabolomics Market
20.1. Russia Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Metabolomics Market
21.1. North America Metabolomics Market Overview
21.2. North America Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Metabolomics Market
22.1. USA Metabolomics Market Overview
22.2. USA Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Metabolomics Market
23.1. South America Metabolomics Market Overview
23.2. South America Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Metabolomics Market
24.1. Brazil Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Metabolomics Market
25.1. Middle East Metabolomics Market Overview
25.2. Middle East Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Metabolomics Market
26.1. Africa Metabolomics Market Overview
26.2. Africa Metabolomics Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Metabolomics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Metabolomics Market Competitive Landscape and Company Profiles
27.1. Metabolomics Market Competitive Landscape
27.2. Metabolomics Market Company Profiles
27.2.1. Human Metabolome Technologies
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Metabolon
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bio-Rad Laboratories
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Bruker
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Agilent Technologies
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Metabolomics Market29. Metabolomics Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Sciex
  • Biocrates Life Sciences
  • Bruker
  • Danaher Corporation
  • Kore Technologies Ltd.
  • Metabolon
Major players in the metabolomics market are Human Metabolome Technologies, Metabolon, Bio-Rad Laboratories, Bruker and Agilent Technologies.

The global metabolomics market is expected to grow from $2.03 billion in 2020 to $2.26 billion in 2021 at a compound annual growth rate (CAGR) of 11.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.6 billion in 2025 at a CAGR of 12.3%.

The metabolomics market consists of sales of metabolomics analytical tools, equipment and related services. Metabolomics is the field of bio-analytics for quantification and identification of metabolic small molecules such as cell, tissue, organ and biological fluid. Metabolomics includes analytical instruments such as liquid chromatography, gas chromatography, capillary electrophoresis, mass spectrometry and nuclear magnetic resonance spectroscopy.

The metabolomics market covered in this report is segmented by product & service into metabolomics instruments, metabolomics bioinformatics tools & services. It is also segmented by application into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, others; by indication into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, others; by metabolomics instruments into separation techniques, detection techniques and by metabolomics bioinformatics tools & services into bioinformatics tools and database, bioinformatics services.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The increasing complexity in interpreting data act as a restraint hindering the metabolomics market growth. Metabolomics tools generate huge quantum of data through metabolomics techniques and the generated data keeps changing not static, hence increasing the difficultly in interpretation of data. For instance, data generated by nuclear magnetic resonance (NMR) Spectroscopy, an analytical technique used for metabolic profiling (a method to measure and interpret various low molecular weight and other intermediates), is difficult to process and interpret. High-level statistical techniques are required for classification and analysis of this data to uncover the biological knowledge which is time-consuming and expensive, restraining the metabolomics market growth.

In January 2018, Biocrates Life Sciences AG, an Austria-based biotechnology company, acquired Metanomics Health GmbH, for an undisclosed amount. This acquisition would strengthen and improve Biocrates Life market share in early disease detection by leveraging the capabilities of Metanomics. Metanomics Health GmbH is a biotechnology company offering metabolomics in life sciences, providing analytical services of metabolite profiling, involved in marketing and developing tools to carry out research and development in healthcare sector. The company was founded in 2002 and is headquartered in Berlin, Germany.

Increasing prevalence rate of cancer drives the metabolomics market growth. Metabolomics screens the potential biomarkers (specific cells, molecules, or genes, gene products, enzymes, or hormones) to measure the cancer drug responsiveness aiding early diagnosis. For instance, according to a report by American Cancer Society in 2019, approximately 1,762,450 new cancer cases were diagnosed in the United States of which the most common cancers are lung cancer, breast cancer, prostate cancer and others. In 2020, according to American Cancer Society, lung cancer is the leading cancer killer in both men and women in the USA, there were 228,820 new cancer cases and 135,720 deaths. Metabolomics approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp, and others have adopted metabolomics as a tool for early detection and cure for cancer.

Machine learning is increasing its popularity in the field of metabolomics due to improve efficiency in interpretation of data generated from metabolomics techniques. Machine learning enabled technologies help in automation of risky and complex processes, avoid repetitive and time taking processes, provide quick and error-free services. Companies in the industry are preferring machine learning techniques for metabolism analysis to solve problems, automate processes and execute tasks. Some of the machine learning algorithms aid in metabolism data analysis and metabolic pathway modelling. Some of the companies such as Bio-Rad Laboratories, Metabolon Inc and others have started using machine learning algorithms for better understanding and prediction in metabolomics study. For instance, MeltDB 2.0, a machine learning software used as a tool for the analysis and integration of metabolomics experiment data that aids research, store experimental data sets. Such machine learning software offer comprehensive analysis and visualization features for the proper representation of the large complex data.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Human Metabolome Technologies
  • Metabolon
  • Bio-Rad Laboratories
  • Bruker
  • Agilent Technologies
  • Thermo Fisher
  • Waters
  • Biocrates Life Sciences
  • Shimadzu
  • Danaher Corporation
  • Kore Technologies Ltd.
  • Dani Instruments S.P.A
  • Perkinelmer Inc.
  • Evans Analytical Group LLC
  • LECO Corporation
  • Phenomenome Discoveries Inc.
  • AB Sciex
  • BG Medicine Inc.
  • Biomark Diagnostics Inc.
  • Chenomx Inc.
  • Creative Proteomics
  • Evotec A.G
  • Merck kgaA
Note: Product cover images may vary from those shown

Loading
LOADING...